Kolibri
Acoustic bioproduction for gene therapies.
Founded
2021
Founders
Amélie Quilichini, Founding CEO
Gabriel Dumy, CTO
Kolibri applies acoustic-based agitation to streamline viral vector production for gene therapies. Biomanufacturers benefit from higher yields, consistent batch quality, and reduced process times—addressing key bottlenecks in advanced therapy manufacturing.
Related
2by4
2by4
Your autonomous pre-construction team.
Starting with estimates.
8x
8x
Human orchestration for business outcomes.
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA for cell modulation.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.